CompuGroup Medical SE & C... (CMPVF)

PNK: CMPVF · Real-Time Price · USD

23.85

0.10 (0.42%)

At close: May 01, 2025, 8:00 PM

Compu Medical SE & KGaA Income Statement

Financials in EUR. Fiscal year is January - December.

Fiscal Year	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021
Period Ending	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021
Revenue	1.2B	1.23B	1.24B	1.28B	1.29B	1.3B	1.28B	1.22B	1.19B	1.15B	1.19B	1.2B	1.19B	874.66M	554.67M	269.07M
Cost of Revenue	531M	760.11M	937.61M	968.55M	964.29M	930.9M	911.47M	886.37M	872.65M	865.47M	884.76M	890.53M	886.58M	643.74M	421.07M	205.54M
Gross Profit	665.19M	466.16M	307.24M	311.13M	323.5M	368.81M	365.89M	336.98M	313.95M	287.81M	308.83M	310.89M	305.45M	230.92M	133.59M	63.53M
Operating Income	100.62M	100.53M	134.6M	163.97M	162.48M	173.74M	170.85M	135.16M	122.32M	102.53M	129.65M	146.4M	144.15M	118.07M	59.75M	20.71M
Interest Income	479.57K	1.01M	1.13M	1.17M	1.09M	481.52K	508.02K	440.93K	403.63K	4.05M	3.99M	4.57M	4.62M	970.42K	886.54K	188.05K
Pretax Income	65.37M	40.4M	54.34M	83.07M	77.36M	119.16M	135.44M	104.64M	111.06M	109.99M	113.62M	124.08M	113.91M	94.54M	48.42M	18.89M
Net Income	34.6M	23.52M	30.84M	48.41M	44.27M	75.62M	88.42M	69.58M	75.34M	75.68M	79.81M	87.52M	80.27M	66.13M	33.25M	12.9M
Selling & General & Admin	100.03M	131.05M	180.72M	184.45M	192.48M	226.86M	224.32M	222.45M	212.1M	212.7M	206.54M	191.46M	189.84M	123.84M	82.87M	45.63M
Research & Development	n/a	17.03M	21.27M	25.19M	25.19M	12.51M	12.08M	8.16M	8.16M	3.82M	n/a	n/a	n/a	n/a	n/a	n/a
Other Expenses	472.58M	263.19M	29.56M	37.28M	31.46M	31.79M	29.29M	20.62M	20.47M	27.42M	27.35M	26.97M	28.54M	10.98M	9.03M	2.81M
Operating Expenses	734.75M	535.82M	342.82M	147.16M	161.03M	195.07M	195.03M	201.83M	191.63M	185.28M	179.18M	164.49M	161.3M	112.86M	73.84M	42.82M
Interest Expense	33.34M	35.55M	30.27M	29.22M	27.76M	24.71M	18.51M	13.48M	9.72M	12.43M	12.01M	12.09M	11.15M	6.57M	3.99M	1.55M
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	1.1B	1.13B	1.11B	1.12B	1.13B	1.13B	1.11B	1.09B	1.06B	1.05B	1.06B	1.06B	1.05B	756.6M	494.91M	248.36M
Income Tax Expense	28.18M	14.95M	19.75M	29.36M	27.79M	36.39M	41.54M	31.95M	33.9M	34.1M	33.72M	36.5M	33.6M	28.38M	15.12M	5.97M
Shares Outstanding (Basic)	51.71M	51.71M	51.71M	52.23M	52.23M	52.23M	52.23M	52.23M	52.23M	52.23M	52.23M	52.24M	52.59M	52.88M	52.88M	53.63M
Shares Outstanding (Diluted)	51.71M	51.71M	51.71M	52.23M	52.23M	52.24M	52.3M	52.26M	52.44M	52.23M	52.23M	52.24M	52.59M	55.61M	54.87M	56.06M
EPS (Basic)	0.71	0.50	0.65	1.02	0.94	1.56	1.79	1.37	1.46	1.45	1.52	1.66	1.51	1.24	0.62	0.24
EPS (Diluted)	0.71	0.50	0.65	1.02	0.94	1.56	1.79	1.37	1.46	1.45	1.49	1.62	1.46	1.19	0.60	0.23
EBITDA	211.1M	203.04M	211.88M	233.84M	220.97M	252.14M	262.31M	230.57M	233.7M	234.02M	241.14M	255.7M	244.18M	185.07M	104.85M	44.01M
EBIT	97.35M	77.23M	85.13M	114.15M	105.76M	145.51M	156.24M	120.71M	123.77M	120.7M	116.79M	121.98M	110.89M	88M	46.54M	20.23M
Depreciation & Amortization	113.74M	124.82M	125.77M	125.78M	125.7M	118.1M	117.54M	116.47M	118.07M	121.46M	125.58M	127.26M	128.67M	92.45M	60.6M	31.53M